1.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

2.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

3.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

4.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

5.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

6.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

7.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

8.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

9.

Movement patterns of adult pike (Esox lucius L.) in a Belgian lowland river ; Beweging en migratiepatronen van volwassen snoek in een Belgische laaglandrivier

1.

LLT prescriptions of patients with definite or probable FH, at baseline and at month-6 of follow-up a .

2.

LLT prescriptions of patients with definite or probable FH, at baseline and at month-6 of follow-up a .

3.

LLT prescriptions of patients with definite or probable FH, at baseline and at month-6 of follow-up a .

1.

Statin intensity of patients with definite or probable FH, at baseline and at month-6 of follow-up a .

2.

Statin intensity of patients with definite or probable FH, at baseline and at month-6 of follow-up a .

3.

Statin intensity of patients with definite or probable FH, at baseline and at month-6 of follow-up a .

1.

Demographic and clinical characteristics and comorbidities of patients with definite, probable, possible or unlikely FH, at baseline a .

2.

Demographic and clinical characteristics and comorbidities of patients with definite, probable, possible or unlikely FH, at baseline a .

3.

Demographic and clinical characteristics and comorbidities of patients with definite, probable, possible or unlikely FH, at baseline a .

1.

Flowchart of study subjects.

2.

Flowchart of study subjects.

3.

Flowchart of study subjects.

1.

Lipid panel of study subjects at baseline.

2.

Lipid panel of study subjects at baseline.

3.

Lipid panel of study subjects at baseline.

1.

LLT change status of patients with definite or probable FH at 6-month of follow-up.

2.

LLT change status of patients with definite or probable FH at 6-month of follow-up.

3.

LLT change status of patients with definite or probable FH at 6-month of follow-up.

1.

Demographic characteristics and comorbidities of patients with probable or definite FH at baseline.

2.

Demographic characteristics and comorbidities of patients with probable or definite FH at baseline.

3.

Demographic characteristics and comorbidities of patients with probable or definite FH at baseline.

1.

Pharmacological management and clinical outcomes of patients with probable or definite FH, at baseline and at 6-month of follow-up.

2.

Pharmacological management and clinical outcomes of patients with probable or definite FH, at baseline and at 6-month of follow-up.

3.

Pharmacological management and clinical outcomes of patients with probable or definite FH, at baseline and at 6-month of follow-up.

1.

Make it Our Shared Wicked Problems! The "Pathways Evolution Process" Serious Game as Challenger for RWM strategies

2.

Make it Our Shared Wicked Problems! The "Pathways Evolution Process" Serious Game as Challenger for RWM strategies

3.

Make it Our Shared Wicked Problems! The "Pathways Evolution Process" Serious Game as Challenger for RWM strategies